Oshi Health GI providers, gut-brain specialists, and registered dietitians work together to address your symptoms and find solutions that actually work for you
In recent months, Eli Lilly, the maker of Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy, have each said that they are able to meet the demand for the medications after facing shortages since 2022 due to the drugs' growing popularity
Medications such as opioids, ones affecting gastrointestinal motility, or anticholinergic agents will not particularly benefit from combining semaglutide with their current administration without prior advice from their healthcare providers 9 Potential non-responders : There might be certain individuals who might be afflicted with other underlying diseases, who might not respond accurately to semaglutide therapy
Berberine causes stomach cramps and diarrhea, but the side effects are less severe